Clinical trial

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

NCT01191008

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Latanoprost-timolol maleate fixed combination ophthalmic solution Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2010-10-01

PhaseN/A

Conditions

Glaucomaverified · MONDO: glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

Latanoprost-timolol maleate fixed combination ophthalmic solutionDRUG

Sponsors & collaborators

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01191008 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.